Biggest changeWe plan to seek additional government contracts in the future and may reassess the classification of such contracts as revenue based on business strategy. 22 Table of Contents Results of Operations Comparison of Years Ended December 31, 2023 and 2022 The following table summarizes our results of operations on a consolidated basis for the years ended December 31, 2023 and 2022 (in thousands, except share and per share data): Year Ended December 31, 2023 2022 $ Change % Change Revenues Product sales and other $ 672 $ 2,106 $ (1,434) (68.1) % Total revenues 672 2,106 (1,434) (68.1) % Cost of revenues Product sales and other 1,716 8,778 (7,062) (80.5) % Total cost of revenues 1,716 8,778 (7,062) (80.5) % Gross loss (1,044) (6,672) 5,628 (84.4) % Operating expenses Research and development 82,240 110,370 (28,130) (25.5) % Selling, general and administrative 42,611 41,988 623 1.5 % Exit and termination costs 11,474 — 11,474 N/A Total operating expenses 136,325 152,358 (16,033) (10.5) % Loss from operations (137,369) (159,030) 21,661 (13.6) % Interest income 13,808 5,724 8,084 141.2 % Gain (loss) on impairment and disposal of assets 1 (19) 20 N/A Other income (expense), net 50 (32) 82 N/A Net loss $ (123,510) $ (153,357) $ 29,847 (19.5) % Net loss per share, basic and diluted $ (0.68) $ (0.87) $ 0.19 (21.8) % Weighted-average shares outstanding, basic and diluted 181,411,069 175,400,486 6,010,583 3.4 % Revenue Sales associated with our Hybrid products decreased $1.4 million.
Biggest changeBeginning in the quarter ending December 31, 2024, we no longer record amounts received for the performance of R&D services as other income (expense) and now record such amounts received as revenue. 23 Table of Contents Results of Operations Comparison of Years Ended December 31, 2024 and 2023 The following table summarizes our results of operations on a consolidated basis for the years ended December 31, 2024 and 2023 (in thousands, except share and per share data): Year Ended December 31, 2024 2023 $ Change % Change Revenues Product sales and other $ — $ 672 $ (672) (100.0) % Research and development services 1,509 — 1,509 N/A Total revenues 1,509 672 837 124.6 % Cost of revenues Product sales and other — 1,716 (1,716) (100.0) % Research and development services 1,415 — 1,415 N/A Total cost of revenues 1,415 1,716 (301) (17.5) % Gross profit (loss) 94 (1,044) 1,138 (109.0) % Operating expenses Research and development 37,004 82,240 (45,236) (55.0) % Selling, general and administrative 24,382 42,611 (18,229) (42.8) % Exit and termination costs 3,007 11,474 (8,467) (73.8) % Total operating expenses 64,393 136,325 (71,932) (52.8) % Loss from operations (64,299) (137,369) 73,070 (53.2) % Interest income 12,216 13,808 (1,592) (11.5) % Gain on disposal of assets 3 1 2 200.0 % Other income, net 32 50 (18) (36.0) % Net loss $ (52,048) $ (123,510) $ 71,462 (57.9) % Net loss per share, basic and diluted $ (0.30) $ (0.68) $ 0.38 (55.9) % Weighted-average shares outstanding, basic and diluted 174,915,487 181,411,069 (6,495,582) (3.6) % Revenue and Cost of Revenues In the fourth quarter of 2024, we began recognizing revenue for R&D services performed as both a prime and subcontractor to the United States government.
Acquisitions and Disposals Disposals O n November 7, 2023, the Board approved a strategic plan to wind down its powertrain business and preserve technology relating to the powertrain business, to better align its workforce with the Company’s future needs, and to reduce the Company’s operating costs (the “Plan”).
Disposals O n November 7, 2023, the Board approved a strategic plan to wind down its powertrain business and preserve technology relating to the powertrain business, to better align its workforce with the Company’s future needs, and to reduce the Company’s operating costs (the “Plan”).
Our cash requirements beyond twelve months include: • Leases — Refer to Note 9 of the notes to the consolidated financial statements for further information of our obligations and the timing of expected payments. • Purchase Commitments — Purchase obligations include non-cancelable purchase commitments related to materials purchase agreements and volume commitments which are entered into from time to time.
Our cash requirements beyond twelve months include: • Leases — Refer to Note 8 of the notes to the consolidated financial statements for further information of our obligations and the timing of expected payments. • Purchase Commitments — Purchase obligations include non-cancelable purchase commitments related to materials purchase agreements and volume commitments which are entered into from time to time.
Due to cumulative losses over recent years and based on all available positive and negative evidence, we have determined that it is not more likely than not that our net deferred tax assets will be realizable as of December 31, 2023.
Due to cumulative losses over recent years and based on all available positive and negative evidence, we have determined that it is not more likely than not that our net deferred tax assets will be realizable as of December 31, 2024.
We believe the credit quality and liquidity of our investment portfolio at December 31, 2023 is strong and will provide sufficient liquidity to satisfy operating requirements, working capital purposes and strategic initiatives.
We believe the credit quality and liquidity of our investment portfolio at December 31, 2024 is strong and will provide sufficient liquidity to satisfy operating requirements , working capital purposes and strategic initiatives.
However, actual results could vary materially and negatively as a result of a number of factors including, but not limited to, those discussed in Part I, Item 1A.
However, actual results could vary materially and adversely as a result of a number of factors including, but not limited to, those discussed in Part I, Item 1A.
Cash from Investing Activities For the year ended December 31, 2023, cash flows provided by investing activities were $18.3 million. Cash used primarily related to the purchase of investments totaling $189.7 million and property and equipment of $7.4 million, offset by the sale or maturity of investments of $215.4 million.
For the year ended December 31, 2023, cash flows used in investing activities were $18.3 million. Cash used primarily related to the purchase of investments totaling $189.7 million and property and equipment of $7.4 million, offset by the sale or maturity of investments of $215.4 million.
Contractual Obligations and Capital Resources We manage our use of cash in the operation of our business to support the execution of our primary strategic goals including the design, development and sale of the KARNO generator. We primarily use cash for research and development activities, capital investments and general and administrative costs.
Contractual Obligations and Capital Resources We manage our use of cash in the operation of our business to support the execution of our primary strategic goals including the design, development and sale of the KARNO generator. We primarily use cash for R&D activities, capital investments and general and administrative costs.
Factors reviewed include the cumulative pre-tax book income for the past three years, 27 Table of Contents scheduled reversals of deferred tax liabilities, our history of earnings and reliable forecasting, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies.
Factors reviewed include the cumulative pre-tax book income for the past three years, scheduled reversals of deferred tax liabilities, our history of earnings and reliable forecasting, projections of pre-tax book income over the foreseeable future, and the impact of any feasible and prudent tax planning strategies.
The preparation of these consolidated financial statements requires us to make estimates 25 Table of Contents and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the balance sheet date, as well as the reported expenses incurred during the reporting period.
The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the balance sheet date, as well as the reported expenses incurred during the reporting period.
We expect to continue to incur net losses in the short term, as we continue to execute on our strategic initiatives by completing the development and commercialization of the KARNO generator with anticipated initial customer deployments in late 2024.
We expect to continue to incur net losses in the short term, as we continue to execute on our strategic initiatives by completing the development and commercialization of the KARNO generator with anticipated initial customer deployments in 2025.
If there are any modifications or cancellations of the underlying unvested securities, we may be required to accelerate any remaining unearned share-based compensation cost or incur incremental cost. Share-based compensation cost affects our research and development and selling, general and administrative expenses.
If there are any modifications or cancellations of the underlying unvested securities, we may be required to accelerate any remaining unearned share-based compensation cost or incur incremental cost. Share-based compensation cost affects our R&D and selling, general and administrative expenses.
See Recent Accounting Pronouncements issued, not yet adopted under Note 3 – Summary of Significant Accounting Policies in the notes to the 2023 consolidated financial statements for more information about recent accounting pronouncements, the timing of their adoption and our assessment, to the extent we have made one, of their potential impact on our financial condition and results of operations.
See Recent Accounting Pronouncements under Note 3 – Summary of Significant Accounting Policies in the notes to the 2024 consolidated financial statements for more information about recent accounting pronouncements, the timing of their adoption and our assessment, to the extent we have made one, of their potential impact on our financial condition and results of operations.
Research and Development Expense Research and development expenses consist primarily of costs incurred for the discovery and development of our KARNO stationary generator and electrified powertrain solutions, which include: • personnel-related expenses including salaries, benefits, travel and share-based compensation, for personnel performing research and development activities; • fees paid to third parties such as contractors for outsourced engineering services and to consultants; • expenses related to components for development and testing, materials, supplies and other third-party services; • depreciation for equipment used in research and development activities; • acquired in-process research and development from asset acquisition; and • allocation of general overhead costs.
Research and Development Expense R&D expenses consist primarily of costs incurred for the discovery and development of our KARNO stationary generator, which include: • personnel-related expenses including salaries, benefits, travel and share-based compensation, for personnel performing R&D activities; • fees paid to third parties such as contractors for outsourced engineering services and to consultants; • expenses related to components for development and testing, materials, supplies and other third-party services; • depreciation for equipment used in R&D activities; and • allocation of general overhead costs.
As of December 31, 2023, there were no such non-cancelable purchase commitments. Refer to Note 2 of the notes to the consolidated financial statements for further information of our exit obligations and the timing of expected payments.
As of December 31, 2024, 26 Table of Contents there were no such non-cancelable purchase commitments. Refer to Note 2 of the notes to the consolidated financial statements for further information on our exit obligations and the timing of expected payments.
Longer term, our capital needs will be determined by our go-to-market strategy, which may include development of our own KARNO generator manufacturing capacity or outsourcing this work to third parties or business partners. In December 2023, we annou nced an authorized share repurchase program to repurchased up to $20 million of our outstanding common stock.
Longer term, our capital needs will be determined by our go-to-market strategy as well as governmental R&D, which may include development of our own KARNO generator manufacturing capacity or outsourcing this work to third parties or business partners. In December 2023, we announced an authorized share repurchase program to repurchase up to $20 million of our outstanding common stock.
Costs incurred for components acquired prior to our determination of reaching a commercial stage are expensed as research and development 26 Table of Contents costs, resulting in zero cost basis for those components. As a result, moving-average prices for inventory that is capitalized in future periods may be significantly affected by those zero cost items.
Costs incurred for components acquired prior to our determination of reaching a commercial stage are expensed as R&D costs, resulting in zero cost basis for those components. As a result, moving-average prices for inventory that is capitalized in future periods may be significantly affected by those zero cost items.
Strategic Business Developments On November 7, 2023, the board of directors (the “Board”) of the Company approved a strategic plan to wind down its powertrain business and preserve technology relating to the powertrain business, to better align its workforce with the Company’s future needs, and to reduce the Company’s operating costs (the “Plan”).
Exit and Termination Costs On November 7, 2023, the Board approved a strategic plan to wind down its powertrain business and preserve technology relating to the powertrain business, to better align its workforce with the Company’s future needs, and to reduce the Company’s operating costs (the “Plan”).
Cost of Revenue Cost of revenue includes all direct costs such as labor and materials, overhead costs, warranty costs and any write-down of inventory to net realizable value.
Cost of Revenue Cost of revenue includes all direct costs such as labor and materials, overhead costs, warranty costs and any write-down of inventory to net realizable value, and costs associated with R&D services revenue.
These costs are a result of the Plan approved on November 7, 2023 to wind down our powertrain business to better align its workforce with the Company’s future needs. Other Income (Expense) Other income currently consists primarily of interest income earned on our investments.
These costs are a result of the plan approved on November 7, 2023 to wind down our powertrain business. Other Income (Expense) Other income currently consists primarily of interest income earned on our investments.
Cash Flows Net cash, cash equivalents and restricted cash provided by or used in operating activities, investing activities and financing activities is summarized as follows for the periods indicated and should be read in conjunction with our consolidated financial statements and the notes thereto included in Part II, Item 8 of this Annual Report on Form 10-K (in thousands): Year Ended December 31, 2023 2022 Cash from operating activities $ (116,962) $ (116,877) Cash from investing activities 18,308 (22,022) Cash from financing activities (15) (78) $ (98,669) $ (138,977) Cash from Operating Activities For the year ended December 31, 2023, cash flows used in operating activities were $117.0 million.
Cash Flows Net cash, cash equivalents and restricted cash provided by or used in operating activities, investing activities and financing activities is summarized as follows for the periods indicated and should be read in conjunction with our consolidated financial statements and the notes thereto included in Part II, Item 8 of this Annual Report on Form 10-K (in thousands): Year Ended December 31, 2024 2023 Cash from operating activities $ (56,738) $ (116,962) Cash from investing activities 59,493 18,308 Cash from financing activities (14,327) (15) $ (11,572) $ (98,669) Cash from Operating Activities For the year ended December 31, 2024, cash flows used in operating activities were $56.7 million.
We expect to continue to invest in research and development activities to achieve operational and commercial goals.
We expect to continue to invest in R&D activities to achieve operational and commercial goals.
“Risk Factors.” The amount and timing of our future funding requirements, if any, will depend on many factors, including the pace and results of our research and development efforts, the breadth of product offerings we plan to commercialize, the pace of sales, and our long-term plan manufacturing plan for the KARNO generator including plans for financing additive printer investments, as well as factors that are outside of our control.
“Risk Factors.” The amount and timing of our future funding requirements, if any, will depend on many factors, including the scope and results of our R&D efforts, the breadth of product offerings we plan to commercialize, the growth of sales, working capital needs, and our long-term manufacturing plan for the KARNO generator including the pace of investments in additive manufacturing assets, methods of financing these investments, as well as factors that are outside of our control.
The Company also has R&D credits of $4.7 million that begin to expire in 2037. Deferred tax assets are regularly assessed to determine the likelihood they will be realized from future taxable income. A valuation allowance is established when we believe it is not more likely than not all or some of a deferred tax asset will be realized.
Deferred tax assets are regularly assessed to determine the likelihood they will be realized from future taxable income. A valuation allowance is established when we believe it is not more likely than not all or some of a deferred tax asset will be realized.
For the year ended December 31, 2022, cash flows used in operating activities were $116.9 million.
For the year ended December 31, 2023, cash flows used in operating activities were $117.0 million.
Exit and Termination Costs Exit and termination costs consist of employee severance and retention payments, accelerated non-cash stock-based compensation expense, contract termination and other cancellation costs, and non-cash charges including accelerated depreciation and amortization.
Exit and Termination Costs Exit and termination costs consist of employee severance and retention payments, accelerated non-cash stock-based compensation expense, contract termination and other cancellation costs, non-cash charges including accelerated depreciation and amortization, carrying value adjustment to assets held for sale, and recoveries from resale of assets.
During the periods presented, we did not have any relat ionships with unconsolidated organizations or financial partnerships, such as structured finance or special purpose entities, which were established for the purpose of facilitating off-balance sheet arrangements.
We regularly evaluate our funding needs and sources of capital and may seek external funding in the appropriate circumstances. During the periods presented, we did not have any relationships with unconsolidated organizations or financial partnerships, such as structured finance or special purpose entities, which were established for the purpose of facilitating off-balance sheet arrangements.
We repurchased $33 thousand in common stock during the year ended December 31, 2023. Based on current projections of operating expenses, capital spending, working capital growth and share repurchases, we expect to have between $220 and $230 million in cash, short-term and long-term investments remaining on our balance sheet at the end of 2024.
Based on current projections of operating expenses, capital spending, working capital growth and historical share repurchases, we expect to have approximately $160 million in cash, short-term and long-term investments remaining on our balance sheet at the end of 2025.
The amount and timing of our future funding requirements, if any, will depend on many factors, including but not limited to the pace of completing initial KARNO generator design, testing and validation, the pace at which we introduce initial generator units to the market, our strategies for manufacturing KARNO generator components (whether in-house or through outsourcing to third parties), the range of product offerings we plan to bring to market and external market factors beyond our control. 21 Table of Contents Key Components of Statements of Operations Revenue We historically generated revenues from sales of Hybrid systems for Class 8 semi-trucks and limited quantities of Class 8 semi-trucks outfitted with the Hybrid system.
The amount and timing of our future funding requirements, if any, will depend on many factors, including but not limited to the pace of completing initial KARNO generator testing and validation, the pace at which we invest in generator additive printing capacity, our plans for manufacturing KARNO generator components (whether in-house or through outsourcing to third parties), the range of product offerings we plan to bring to market and external market factors beyond our control.
We also had $128.2 million of investments in longer-term liquid securities which we maintain to generate higher income on capital that we do not expect to spend in the next 12 months.
Our current liabilities were $14.3 million primarily comprised of accounts payable, accrued expenses and operating lease liabilities. We also had $99.6 million of investments in longer-term liquid securities which we maintain to generate higher income on capital that we do not expect to spend in the next 12 months.
As a result of our strategic review and decision to wind down our powertrain business, we do not anticipate further revenue until we begin commercialization of our KARNO generator. Cost of Revenues Cost of revenues associated with our Hybrid products decreased $7.1 million.
Revenue for R&D services increased $1.5 million and associated cost of revenues increased $1.4 million. Revenue associated with our hybrid products decreased $0.7 million and associated cost of revenues decreased $1.7 million as a result of our strategic review and decision to discontinue our powertrain business.
As a result of the discontinuation of the electrified powertrain systems business and the shift to focus exclusively on the development and commercialization of the Company’s fuel-agnostic KARNO generator technology, we do not anticipate generating future revenues until we begin commercialization of our KARNO generators.
As a result of the discontinuation of the electrified powertrain systems business and the shift to focus on the development and commercialization of the Company’s fuel-agnostic KARNO generator technology, we anticipate generating revenue after commercialization of our KARNO generator. Additionally, we generate revenue from R&D services under contracts with third-parties including the U.S. government.
For the year ended December 31, 2022, cash flows used in investing activities were $22.0 million. Cash used primarily related to the purchase of investments totaling $268.6 million, the cash component of acquired in-process research and development of $14.4 million and property and equipment of $2.9 million, partially offset by the sale or maturity of investments of $263.7 million.
Cash from Investing Activities For the year ended December 31, 2024, cash flows provided by investing activities were $59.5 million. Cash provided related to the purchase of investments totaling $96.3 million and property and equipment of $16.5 million, offset by the sale or maturity of investments of $166.9 million and proceeds from sale of property and equipment of $5.4 million.
We do not undertake, and expressly disclaim, any obligation to publicly update any forward-looking statements, whether as a result of new information, new developments or otherwise, except to the extent that such disclosure is required by applicable law. 20 Table of Contents Key Factors Affecting Operating Results We believe that our performance and future success depend on several factors that present significant opportunities for us but also pose risks and challenges, including but not limited to current economic uncertainties, supply chain disruptions, inflation and high interest rates as well as those discussed below and referenced in Item 1A “Risk Factors”.
Key Factors Affecting Operating Results We believe that our performance and future success depend on several factors that present significant opportunities for us but also pose risks and challenges, including but not limited to current economic uncertainties and supply chain disruptions, as well as those discussed below and referenced in Item 1A “Risk Factors.” 22 Table of Contents Commercialization of KARNO Generator Our focus is on continuing development and testing of our fuel-agnostic KARNO stationary generator and planning for the deployment of initial units with customers in 2025.
Research and Development Research and development expenses decreased $28.1 million due to: • A decrease of $28.8 million related to KARNO technology acquired in September 2022 from General Electric Company’s GE Additive business to develop and commercialize the fuel agnostic KARNO generator; and • A decrease of $13.4 million for the design and testing of our Hypertruck ERX system; offset by • An increase of $14.1 million for the design and testing of our KARNO stationary generator. 23 Table of Contents Selling, General and Administrative Selling, general, and administrative expenses increased $0.6 million primarily due to: • An increase of $1.3 million in professional services and other one-time charges; and • An increase of $1.2 million in personnel and benefits, offset by costs related to the prior-year departure of our previous Chief Financial Officer; partially offset by • A decrease of $2.3 million for insurance costs.
Research and Development R&D expenses decreased $45.2 million due to: • a decrease of $63.6 million for the design and testing of our Hypertruck ERX system due to our strategic decision to wind down our powertrain business; offset by • an increase of $18.4 million for the design and testing of our KARNO stationary generator. 24 Table of Contents Selling, General and Administrative Selling, general, and administrative expenses decreased $18.2 million primarily due to wind down of our powertrain business: • a decrease of $9.3 million in personnel and benefits; • a decrease of $3.7 million in professional services; • a decrease of $1.1 million in marketing; and • a decrease of $1.1 million in insurance.
Cash from Financing Activities For the year ended December 31, 2023, cash flows used in financing activities were nil. For the year ended December 31, 2022, cash flows used in financing activities were $0.1 million. Cash flows were primarily due to payment of taxes related to net share settlement of equity awards of $0.2 million.
Cash from Financing Activities For the year ended December 31, 2024, cash flows used in financing activities were $14.3 million, primarily due to stock repurchases.
Successful Commercialization of KARNO Generator Our focus in the fourth quarter of 2023 was on continuing development and testing of our fuel-agnostic KARNO stationary generator and deploying initial revenue-generating units with customers in 2024. We anticipate that a substantial portion of our capital resources and efforts in the near future will be focused these activities.
We anticipate that a substantial portion of our capital resources and efforts in the near future will be focused these activities.
Exit and Termination Costs Exit and termination costs of $11.5 million were a result of the strategic plan and items discussed in Note 2 of the notes to the consolidated financial statements. Other Income (Expense ) Total other income increased $8.2 million prim arily due to an increase in interest income on investments.
Exit and termination costs decreased by $8.5 million as a result of the adoption of the Plan and items discussed in Note 2 of the notes to the consolidated financial statements, including recoveries from assets sold. Interest Income Interest income decreased $1.6 million primarily due to the decline in our investment balance.
Liquidity and Capital Resources At December 31, 2023, our current assets were $181.7 million, consisting primarily of cash and cash equivalents of $12.9 million, short-term investments of $150.3 million, and prepaid expenses of $18.5 million. Our current liabilities were $15.1 24 Table of Contents million primarily comprised of accounts payable, accrued expenses and operating lease liabilities.
For the year ended December 31, 2023, cash flows used in financing activities were nil. 25 Table of Contents Liquidity and Capital Resources At December 31, 2024, our current assets were $131.0 million, consisting primarily of cash and cash equivalents of $9.2 million, short-term investments of $110.9 million, and prepaid expenses of $6.4 million.
Cash used primarily related to a net loss of $153.4 million, adjusted for $8.7 million change in working capital accounts and $45.2 million in certain non-cash expenses (including $28.8 million related to acquired in-process research and development comprised of the non-cash component and the cash component attributable to investing activities, $7.0 million related to share-based compensation, $5.6 million related to inventory write-downs and $2.5 million related to depreciation, amortization and accretion charges).
Cash used primarily related to a net loss of $52.0 million, adjusted for $14.6 million change in working capital accounts and $9.9 million in certain non-cash expenses (including $6.5 million related to carrying value adjustments to assets held for sale offset by $2.9 million in gains on asset sales, $4.6 million related to share-based compensation, and $1.6 million related to lease charges, inclusive of $1.1 million received for tenant improvements).
Incom e Taxes We recognize deferred taxes for temporary differences between the basis of assets and liabilities for financial statement and income tax purposes. At December 31, 2023, we had federal net operating loss carryforwards of $297.9 million and state net operating loss carryforwards of $12.5 million that expire in various years starting in 2036.
At December 31, 2024, we had federal net operating loss carryforwards of $346.2 million and state net operating loss carryforwards of $12.5 million that expire in various years starting in 2036. The Company also has R&D credits of $4.7 million that begin to expire in 2037.
We do not expect to need to raise additional equity capital for the foreseeable future. Our primary short-term cash needs are costs associated with KARNO generator development and the exit from our powertrain business.
Our primary short-term cash needs are costs associated with KARNO generator development, building our initial deployment units and capital investments for additive printer acquisitions.